[1]LEE DH,GOLDBER AL.Proteasome inhibitors:valuable new tools for cell biologists[J].Trends in Cell Biology,1998,8(10):397-403.
[2]DONOHUE TM.The ubiquitin-proteasome system and its role in ethanol-induced disorders[J].Addiction Biology,2010,7(1):15-28.
[3]SHEN M,SCHMITT S,BUAC D,et al.Targeting the ubiquitin-proteasome system for cancer therapy[J].Cancer Science,2013,17(9):1091-1108.
[4]GONG W,ZHANG X,ZHANG W,et al.Structure of the HECT domain of human WWP2[J].Acta Crystallographica,2015,71(10):1251-1257.
[5]TU Y,CHEN C,PAN J,et al.The ubiquitin proteasome pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis[J].International Journal of Clinical & Experimental Pathology,2012,5(8):726-738.
[6]ZHANG R,ZHANG J,LUO W,et al.WWP2 is one promising novel oncogene[J].Pathology & Oncology Research,2019,25:443-446.
[7] LI W,BENGTSON MH,ULBRICH A,et al.Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN,a mitochondrial E3 that regulates the organelle' dynamics and signaling[J].PLoS One,2008,3(1):e1487.
[8]MARBLESTON JG,BUTT S,MCKELVEY DM,et al.Comprehensive ubiquitin E2 profiling of ten ubiquitin E3 ligases[J].Cell Biochemistry & Biophysics,2013,67(1):161-167.
[9]DING F.The role of the ubiquitin-proteasome pathway in cancer development and treatment[J].Frontiers in Bioence,2014,19(6):886.
[10]SCHEFFNER M,NUBER U,HUIBREGTSE JM.Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade[J].Nature,1995,373(6509):81-83.
[11]ARRIGONI A,GRILLO B,VITRIOLO A,et al.C-terminal acidic domain of ubiquitin-conjugating enzymes:A multi-functional conserved intrinsically disordered domain in family 3 of E2 enzymes[J].Journal of Structural Biology,2012,178(3):245-259.
[12]OLSEN S,LIMA C.Structure of a ubiquitin E1-E2 complex:insights to E1-E2 thioester transfer[J].Molecular Cell,2013,49(5):884-896.
[13]LEE I,SCHINDELIN H.Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes[J].Cell,2008,134(2):268-278.
[14]CHEN FZ,ZHAO XK.Ubiquitin-proteasome pathway and prostate cancer[J].Onkologie,2013,36(10):592-596.
[15]WEBER J,POLO S,MASPERO E.HECT E3 ligases:a tale with multiple facets[J].Frontiers in Physiology,2019,10:370.
[16]YANG JH,WO D,YAN HW,et al.Bioinformatic and antiviral functional analysis of WW domain containing E3 ubiquitin protein ligase 2 gene[J].Journal of Food,Agriculture & Environment,2014,12(2):118-123.
[17]ZINZALLA G.Paving the way to targeting HECT ubiquitin ligases[J].Future Medicinal Chemistry,2015,7(16):2107-2111.
[18]SADOWSKI M,SURYADINATA R,TAN AR,et al.Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes[J].Iubmb Life,2012,64(2):136-142.
[19]STREICH FC,LIMA CD.Structural and functional insights to ubiquitin-like protein conjugation[J].Annual Review of Biophysics,2014,43(1):357-379.
[20]KRISTIE AD,ALEXANDER JC,ANTHONY JG,et al.The RING fifinger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer[J].Human Molecular Genetics.2016,25(24):5460-5471.
[21]YU YH,LI XZ,GUO DL,et al.Genome-wide identification and analysis of the U-box family of E3 ligases in grapevine[J].Russian Journal of Plant Physiology.2016,63(6):835-848.
[22]RYU MY,CHO SK,HONG Y,et al.Classification of barley U-box E3 ligases and their expression patterns in response to drought and pathogen stresses[J].BMC Genomics,2019,20(1):326.
[23]BOASE NA,KUMAR S.NEDD4:The founding member of a family of ubiquitin-protein ligases[J].Gene,2015,557(2):113-122.
[24]MARNEROS A,ALEXANDER G.A role for the E3 ubiquitin ligase NEDD4 in keloid pathogenesis[J].Journal of Investigative Dermatology,2019,139:279-280.
[25]WOOD JD,YUAN J,MARGOLIS RL,et al.Atrophin-1,the DRPLA gene product,interacts with two families of WW domain-containing proteins[J].Mol Cell Neuro,1998,11(3):149.
[26]MADDIKA S,KAVELA S,RANI N,et al.WWP2 is an E3 ubiquitin ligase for PTEN[J].Nature Cell Biology,2011,13(6):728.
[27]SOOND SM,SMITH PG,WAHI L,et al.Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer[J].Biochimica et Biophysica Acta,2013,1832(12):2127-2135.
[28]SOOND SM,CHANTRY A.Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT[J].Oncogene,2011,30(21):2451.
[29]ANDREW CHANTRY.WWP2 ubiquitin ligase and its isoforms:new biological insight and promising disease targets[J].Cell Cycle (Georgetown,Tex.),2011,10(15):2437-2439.
[30]WAHI LC,WATT JE,BOURCIER DD,et al.WW domains from WWP2 E3 ubiquitin ligase recognise Oct4 and Smad7 peptides[J].Biophysical Journal,2020,118(3):182a.
[31]LIAO B,JIN Y.Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner[J].Cell Research,2010(3):332-344.
[32]XU HM,LIAO B,ZHANG QJ,et al.Wwp2,an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination[J].Journal of Biological Chemistry,2004,279(22):23495-23503.
[33]XU H,WANG W,LI C,et al.WWP2 promotes degradation of transcription factor OCT4 in human embryonic stem cells[J].Cell Research,2009,19(5):561-573.
[34]CHEN W,JIANG X,LUO Z.WWP2:a multifunctional ubiquitin ligase gene[J].Pathology Oncology Research Por,2014,20(4):799-803.
[35]LIANG J,QI W F,XIE S,et al.Expression of WW domain-containing protein 2 is correlated with pathological grade and recurrence of glioma[J].Journal of Cancer Research & Therapeutics,2017,13(6):1032.
[36]TATENDA M,BHUVIC P,HAO C,et al.Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma[J].Nature Communications,2021,12:6321-6337.
[37]YANG R,HE Y.Elevated expression of WWP2 in human lung adenocarcinoma and its effect on migration and invasion[J].Biochemical & Biophysical Research Communications,2016,479:146-151.
[38]WANG L,SHEN S,XIAO HB,et al.ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-P27 axis[J].Carcinogenesis,2020,41(5):711-721.
[39]LI DQ,ZHANG JL,YIN LJ,et al.Etomidate inhibits cell proliferation and induces apoptosis in A549 non-small cell lung cancer cells via downregulationg WWP2[J].Experimental and Therapeutic Medicine,2021,22:1254-1263.
[40]XU S,QIN Y,PAN D,et al.Inhibition of WWP2 suppresses proliferation,and induces G1 cell cycle arrest and apoptosis in liver cancer cells[J].Molecular Medicine Reports,2016,13:2261-2266.
[41]COSTA C,SUZANNE LT,SUSAN JT,et al.Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD[J].The European Respiratory Journal,2016,47(4):1093-1102.
[42]DAGAN BM,FENIGER BR,AVNIEL S,et al.Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration,adhesion and internalization in response to CXCL11[J].Blood,2006,107(10):3821-3831.
[43]VELASCO-VELZQUEZ M,JIAO X,DELA FM,et al.CCR5 antagonist blocks metastasis of basal breast cancer cells[J].Cancer Res,2012,72:3839-3850.
[44]FANG SJ,ZHANG DK,WENG W,et al.CPSF7 regulates liver cancer growth and metastasis by facilitating WWP2-FL and targeting the WWP2/PTEN/AKT signaling pathway[J].Biochimica et Biophysica Acta.Molecular Cell Research,2020,1867(2):118624.
[45]QIN Y,XU SQ,PAN DB,et al.Silencing of WWP2 inhibits adhesion,invasion,and migration in liver cancer cells[J].Tumour Biology,2016,37(5):6787-6799.
[46]BOOSANI CHANDRA S,GUNASEKAR PALANIKUMAR,AGRAWAL DEVENDRA K.An update on PTEN modulators-a patent review[J].Expert Opinion on Therapeutic Patents,2019,29(11):881-889.
[47]QIN Y,WANG CJ,YE GX,et al.WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma[J].Cell Biology International[2022-07-26].https://doi.org/10.1002/cbin.11856.
[48]HU ML,ZHU SX,XIONG SW,et al.MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review)[J].Oncology Reports,2019,41(3):1439-1454.
[49]FUKUMOTO C,NAKASHIMA D,KASAMATSU A,et al.WWP2 is overexpressed in human oral cancer,determining tumor size and poor prognosis in patients:downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice[J].Oncoence,2014,1(12):807-820.
[50]KURASAWA Y,SHIIBA M,NAKAMURA M,et al.PTEN expression and methylation status in oral squamous cell carcinoma[J].Oncology Reports,2008,19(6):1429-1434.
[51]LI HC,ZHANG PF,ZHANG QY,et al.WWP2 is a physiological ubiquitin ligase for phosphatase and tensin homolog (PTEN) in mice[J].The Journal of Biological Chemistry,2018,293(23):8886-8899.
[52]WANG K,LIU J,ZHAO X,et al.WWP2 regulates proliferation of gastric cancer cells in a PTEN-dependent manner[J].Biochemical and Biophysical Research Communications,2020,521(3):652-659.
[53]GE MX,LIU HT,ZHANG N,et al.Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation[J].British Journal of Pharmacology,2020,177(2):372-387.
[54]KENT S,HUTCHINOSON J,BALBONI A,et al.ΔNp63α promotes cellular quiescence via induction and activation of Notch3[J].Cell Cycle,2011,10(18):3111-3118.
[55]VON GRABOWIECKI Y,LICONA C,PALAMIUC L,et al.Regulation of a Notch3-Hes1 pathway and protective effect by a tocopherol-omega alkanol chain derivative in muscle atrophy[J].Journal of Pharmacology & Experimental Therapeutics,2015,352(1):23-32.
[56]ZABURJANIA Z,JANG S,WHITT J,et al.The role of Notch3 in cancer[J].Oncologist,2018,23:1-12.
[57]JUNG JG,STOECK A,GUAN B,et al.Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer[J].Plos Genetics,2014,10(10):e1004751.
[58]CLEMENTS AE,BRAVO V,KOIVISTO C,et al,WWP2 and its association with PTEN in endometrial cancer[J].Gynecologic Oncology Reports,2015,13:26-29.
[59]LIU J,WAN LX,LIU J,et al.Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner[J].Cell Discovery,2016,2:15044.
[60]TASNEEM BK,YANG FM,RITHO J,et al.SENP1 regulates PTEN stability to dictate prostate cancer development[J].Oncotarget,2017,8(11):17651-17664.
[61]TASNEEM BK,CHENG JK,WANG ZX,et al.Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells[J].The Journal of Biological Chemistry,2007,282(52):37341-37349.
[62]CHEN Z,THOMAS SN,BOLDUC DM,et al.Enzymatic analysis of PTEN ubiquitylation by WWP2 and NEDD4-1 E3 ligases[J].Biochemistry,2016,55:3658-3666.
[63]YU ZL,LI T,WANG C,et al.Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells[J].Oncotarget,2016,7(13):15725-15737.
[64]FU H,JIN CH,ZHU QX,et al.Dysregulated expressions of PTEN,NF-κB,WWP2,p53 and c-Myc in different subtypes of B cell lymphoma and reactive follicular hyperplasia[J].American Journal of Translational Research,2019,11(2):1092-1101.
[65]LONGO V,BRUNETTI O,D'ORONZO S,et al.Therapeutic approaches to myeloma bone disease:An evolving story[J].Cancer Treatment Reviews,2012,38(6):787-797.
[66]李安娜.WWP2和PTEN在再生障碍性贫血中的表达研究[D].南昌:南昌大学,2016:1-38.
LI AN.WWP2 and PTEN expression in aplastic anemia[D].Nanchang:Nanchang University,2016:1-38.
[67]ZHANG QG,GONG WY,WU J,et al.DKK1 suppresses WWP2 to enhance bortezomib resistance in multiple myeloma via regulating GLI2 ubiquitination[J].Carcinogenesis,2021,42(10):1223-1231.
[68]MIYAKI S,SATO T,INOUE A,et al.MicroRNA-140 plays dual roles in both cartilage development and homeostasis[J].Genes & Development,2010,24(11):1173-1185.
[69]ZOU WG,CHEN X,SHIM JH,et al.The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid[J].Nature Cell Biology,2011,13(1):59-65.
[70]MOKUDA S,NAKAMICHI R,MATSUZAKI T,et al.Wwp2 maintains cartilage homeostasis through regulation of Adamts5[J].Nature Communications,2019,10(1):2429.
[71]FOSANG AJ,ROGERSON FM,EAST CJ,et al.ADAMTS-5:The story so far[J].European Cells & Materials,2008,15(8):11.
[72]CHE H,HE WL,FENG J,et al.WWP2 ameliorates acute kidney injury by mediating p53 ubiquitylation and degradation[J].Cell Biochemistry and Function,2020,38(6):695-701.
[73]RILEY T,SONTAG E,CHEN P,et al.Transcriptional control of human p53-regulated genes[J].Nat Rev Mol Cell Biol,2008,9:402-412.
[74]PANT V,LOZANO G.Limiting the power of p53 through the ubiquitin proteasome pathway[J].Genes Dev,2015,28(16):1739-1751.
[75]KELLY KJ,PLOTKIN Z,VULGAMOTT SL,et al.P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion:protective role of a p53 inhibitor[J].Journal of the American Society of Nephrology,2003,14(1):128.
[76]ZHANG NJ,ZHANG Y,QIAN H,et al.Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling[J].Cell Death and Differentiation,2020,27(9):2605-2619.
[77]ZHANG Y,YOU SL,TIAN YC,et al.WWP2 regulates SIRT1-STAT3 acetylation and phosphorylation involved in hypertensive angiopathy[J].J Cell Mol Med,2020,24:9041-9054.
[78]SONG YB,REN XY,GAO F,et al.LINC01588 regulates WWP2-mediated cardiomyocyte injury by interacting with HNRNPL[J].Environmental Toxicology,2022,37(7):1529-1641.
[79]WANG XY,MA L,ZHANG SL,et al.WWP2 ameliorates oxidative stress and inflammation in atherosclerotic mice through regulation of PDCD4/HO-1 pathway[J].Acta Biochi Biophys Sin,2022,54(8):1-11.